» Articles » PMID: 32157664

A Unique Neuroendocrine Cell Model Derived from the Human Foetal Neural Crest

Overview
Publisher Springer
Specialty Endocrinology
Date 2020 Mar 12
PMID 32157664
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Nowadays, no human neuroendocrine cell models derived from the neural crest are available. In this study, we present non-transformed long-term primary Neural Crest Cells (NCCs) isolated from the trunk region of the neural crest at VIII-XII gestational weeks of human foetuses obtained from voluntary legal abortion.

Methods And Results: In NCC, quantitative real-time RT PCR demonstrated the expression of neural crest specifier genes, such as Snail1, Snail2/SLUG, Sox10, FoxD3, c-Myc, and p75NTR. Moreover, these cell populations expressed stemness markers (such as Nanog and nestin), as well as markers of motility and invasion (TAGLN, MMP9, CXCR4, and CXCR7), and of neuronal/glial differentiation (MAP2, GFAP, SYP, and TAU). Functional analysis demonstrated that these cells not only possessed high migration properties, but most importantly, they expressed markers of sympatho-adrenal lineage, such as ASCL1 and tyrosine hydroxylase (TH). Moreover, the expression of TH increased after the induction with two different protocols of differentiation towards neuronal and sympatho-adrenal phenotypes. Finally, exposure to conditioned culture media from NCC induced a mature phenotype in a neuronal cell model (namely SH-SY5Y), suggesting that NCC may also act like Schwann precursors.

Conclusion: This unique human cell model provides a solid tool for future studies addressing the bases of human neural crest-derived neuroendocrine tumours.

Citing Articles

Effect of Multiple-Cycle Collections of Conditioned Media from Different Cell Sources towards Fibroblasts in In Vitro Wound Healing Model.

Fadilah N, Fauzi M, Maarof M Pharmaceutics. 2024; 16(6).

PMID: 38931888 PMC: 11207063. DOI: 10.3390/pharmaceutics16060767.


Human-Based New Approach Methodologies in Developmental Toxicity Testing: A Step Ahead from the State of the Art with a Feto-Placental Organ-on-Chip Platform.

Luconi M, Sogorb M, Markert U, Benfenati E, May T, Wolbank S Int J Environ Res Public Health. 2022; 19(23).

PMID: 36497907 PMC: 9737555. DOI: 10.3390/ijerph192315828.